Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis. It is a sphingosine-1-phosphate receptor modulator...
15 KB (1,066 words) - 21:13, 1 November 2024
multiple sclerosis (SPMS). Subsequently, ozanimod was approved in 2020, and ponesimod was approved in 2021, which were both approved for management of CIS,...
170 KB (18,177 words) - 09:23, 7 November 2024
sclerosis (MS) S1P1 and S1P5 FDA Approved 2019, EMA approved 2020 4. Ponesimod Multiple sclerosis (MS), psoriasis and graft vs. host disease S1P1 FDA...
14 KB (1,555 words) - 16:58, 26 October 2024
Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001 RP-002 RPC-1063 SEW-2871 Siponimod S1P SPC TC-G 1006 TC-SP 14 W-061...
30 KB (3,360 words) - 02:17, 7 November 2024
Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001 RP-002 RPC-1063 SEW-2871 Siponimod S1P SPC TC-G 1006 TC-SP 14 W-061...
27 KB (2,574 words) - 15:29, 18 October 2024
Ixekizumab Netakimab Olokizumab Ozanimod Peficitinib Pegcetacoplan Pirfenidone Ponesimod Ravulizumab Risankizumab Ritlecitinib Rozanolixizumab Sarilumab Satralizumab...
7 KB (299 words) - 13:45, 27 April 2024
Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001 RP-002 RPC-1063 SEW-2871 Siponimod S1P SPC TC-G 1006 TC-SP 14 W-061...
13 KB (811 words) - 02:32, 12 October 2024
Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001 RP-002 RPC-1063 SEW-2871 Siponimod S1P SPC TC-G 1006 TC-SP 14 W-061...
4 KB (220 words) - 20:12, 19 July 2024
Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001 RP-002 RPC-1063 SEW-2871 Siponimod S1P SPC TC-G 1006 TC-SP 14 W-061...
24 KB (2,392 words) - 23:10, 9 September 2024
Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001 RP-002 RPC-1063 SEW-2871 Siponimod S1P SPC TC-G 1006 TC-SP 14 W-061...
34 KB (3,309 words) - 16:05, 18 October 2024